Skeletal Muscle Mass on Prognosis and Recovery in Clinical Trial
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Jun 13, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Non-traumatic adult patients who experienced sudden cardiac arrest
- • Achieved sustained return of spontaneous circulation (ROSC) for more than five minutes following successful resuscitation
- • Admitted to the ICU
- • Survived beyond 72 hours without successful weaning from mechanical ventilation
- Exclusion Criteria:
- • Age under 18 years
- • Pregnancy
- • Expected to be weaned from mechanical ventilation within 48 hours
- • Terminal-stage cancer or unwillingness to receive aggressive treatment
- • Unavailability of ICU care due to overcrowding in the emergency intensive care unit
- • Refusal to participate in the study by the patient or family members
- • Presence of an implanted pacemaker or defibrillator
- • Open wounds, severe edema, or deep vein thrombosis in the lower limbs
- • Pre-arrest status limited to wheelchair use or bedridden, unable to ambulate
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported